Fausta Beneventi

Fausta Beneventi

Auto-generated profile, based on publicly available information

Fausta Beneventi

Department of Obstetrics and Gynecology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy; Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Corso Strada Nuova 65 27100 Pavia, Italy

Research Focus & Metrics

Academic Career Length

81Years (1946-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
ELElisabetta Lovati
Elisabetta Lovati
FBFausta Beneventi
Fausta Beneventi
MSMargherita Simonetta
Margherita Simonetta
MLMarco Laneri
Marco Laneri
LQLara Quarleri
Lara Quarleri
GCGino R. Corazza
Gino R. Corazza

14 March 2011 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
FBFausta Beneventi
Fausta Beneventi
MSMargherita Simonetta
Margherita Simonetta
ELElisabetta Lovati
Elisabetta Lovati
GAGiulia Albonico
Giulia Albonico
CTCarmine Tinelli
Carmine Tinelli
ASArsenio Spinillo
Arsenio Spinillo

18 October 2016 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
ASArsenio Spinillo
Arsenio Spinillo
FBFausta Beneventi
Fausta Beneventi
ELElena Locatelli
Elena Locatelli
VRVèronique Ramoni
Vèronique Ramoni
RCRoberto Caporali
Roberto Caporali
CMCarlomaurizio Montecucco
Carlomaurizio Montecucco
The burden of pregnancy complications associated with well defined, already established systemic rheumatic diseases preexisting pregnancy such as rheumatoid arthritis, systemic lupus erythematosus or scleroderma is well known. Systemic rheumatic diseases are characterized by a long natural history with few symptoms, an undifferentiated picture or a remitting course making difficult a timely diagnosis. It has been suggested that screening measures for these diseases could be useful but the impact of unrecognized systemic rheumatic disorders on pregnancy outcome is unknown. The objective of the study was to evaluate the impact of previously unrecognized systemic autoimmune rheumatic on the incidence of preeclampsia and fetal growth restriction (FGR). A longitudinal cohort-study with enrolment during the first trimester of pregnancy of women attending routine antenatal care using a two-step approach with a self-reported questionnaire, autoantibody detection and clinical evaluation of antibody-positive subjects. The incidence of FGR and preeclampsia in subjects with newly diagnosed rheumatic diseases was compared to that of selected negative controls adjusting for potential confounders by logistic regression analysis. The prevalence of previously unrecognized systemic rheumatic diseases was 0.4 % for rheumatoid arthritis (19/5232), 0.25 % (13/5232) for systemic lupus erythematosus, 0.31 % (16/5232) for Sjögren’s syndrome, 0.3 % for primary antiphospholipid syndrome (14/5232) and 0.11 % (6/5232) for other miscellaneous diseases. Undifferentiated connective tissue disease was diagnosed in an additional 131 subjects (2.5 %). The incidence of either FGR or preeclampsia was 6.1 % (36/594) among controls and 25.3 % (50/198) in subjects with unrecognized rheumatic diseases (excess incidence = 3.9 % (95 % CI = 2.6–9.6) or 34 % (95 % CI = 22–44) of all cases of FGR/preeclampsia). The incidence of small for gestational age infant (SGA) was higher among subjects with unrecognized rheumatic diseases (41/198 as compared to 46/594; adjOdds Ratio = 3.1, 95 % CI =1.96–4.95) than in controls. The excess incidence associated with unrecognized rheumatic diseases was 2.7 % (95 % CI = 1.5–4) or 25 % (95 % CI = 12.8–34.8) of all SGA cases. Unrecognized autoimmune systemic rheumatic disorders are associated with a significant proportion of preeclampsia and fetal growth failure, suggesting that their role in the etiology of adverse pregnancy outcome is probably undervalued.

11 December 2008 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
Valeria CalcaterraValeria Calcaterra
Valeria Calcaterra
PSP. Sampaolo
P. Sampaolo
CKCatherine Marie Klersy
Catherine Marie Klersy
DLD. Larizza
D. Larizza
AAA. Alfei
A. Alfei
MCM. Cisternino
M. Cisternino

1 June 2012 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
ASArsenio Spinillo
Arsenio Spinillo
FBFausta Beneventi
Fausta Beneventi
VRVéronique Ramoni
Véronique Ramoni
RCRoberto Caporali
Roberto Caporali
ELElena Locatelli
Elena Locatelli
CMCarlomaurizio Montecucco
Carlomaurizio Montecucco
Objectives The objective of this study was to evaluate the rates of previously undiagnosed rheumatic diseases during the first trimester of pregnancy and their impact on the pregnancy outcome. Methods Pregnant women in their first trimester were screened using a two-step approach using a self-administered 10-item questionnaire and subsequent testing for rheumatic autoantibodies (antinuclear antibody, anti-double-stranded DNA, anti-extractable nuclear antigen, anticardiolipin antibodies, anti-β2-glycoprotein I antibodies and lupus anticoagulant) and evaluation by a rheumatologist. Overall, the complications of pregnancy evaluated included fetal loss, pre-eclampsia, gestational diabetes, fetal growth restriction, delivery at less than 34 weeks, neonatal resuscitation and admission to the neonatal intensive care unit. Results Out of the 2458 women screened, the authors identified 62 (2.5%) women with previously undiagnosed undifferentiated connective tissue disease (UCTD) and 24 (0.98%) women with previously undiagnosed definite systemic rheumatic disease. The prevalences were seven (0.28%) for systemic lupus erythematosus and Sjogren's syndrome, six (0.24%) for rheumatoid arthritis, three (0.12%) for antiphospholipid syndrome and one (0.04%) for systemic sclerosis. In multiple exact logistic regression, after adjustment for potential confounders, the OR of overall complications of pregnancy were 2.81 (95% CI 1.29 to 6.18) in women with UCTD and 4.57 (95% CI 1.57 to 13.57) in those with definite diseases, respectively, compared with asymptomatic controls. Conclusions In our population approximately 2.5% and 1% of first trimester pregnant women had a previously undiagnosed UCTD and definite systemic rheumatic disease, respectively. These conditions were associated with significant negative effects on the outcome of pregnancy.

1 February 2015 in Fertility and Sterility
Verified
Journal Article
Closed access
FBFausta Beneventi
Fausta Beneventi
ELElena Locatelli
Elena Locatelli
GGGiovanna Giorgiani
Giovanna Giorgiani
MZMarco Zecca
Marco Zecca
TMTommaso Mina
Tommaso Mina
ASArsenio Spinillo
Arsenio Spinillo